2009
DOI: 10.1159/000268133
|View full text |Cite
|
Sign up to set email alerts
|

Mast Cells and Mastocytosis

Abstract: Mast cells (MCs) typically reside at barrier sites of the body, including the intestinal mucosa, and play a vital role in innate host defence. Activated MCs release a wide variety of bioactive mediators. These include preformed mediators stored in the granules (e.g. histamine and tryptase) and newly synthesised mediators (e.g. prostaglandins, leukotrienes and cytokines). MCs are present in all layers throughout the gastrointestinal (GI) tract and there is a close bi-directional connection between MCs and enter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2011
2011
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 114 publications
0
13
0
Order By: Relevance
“…Impaired mast cell apoptosis and interleukin 6 have also been postulated to be involved, as evidenced by BCL-2 up-regulation and IL-6 elevation in tissue. Some activating point mutation of c-kit in codon 816 (usually KITD816V), encoding the tyrosine kinasereceptor for stem cell factor, are found to be associated with systemic form [85][86][87][88][89][90][91][92][93][94][95][96][97][98]. Since Omalizumab reduces the expression of FcεRI on circulating basophils and mast cells, it seems to lower the activity potentials of basophils and mast cells, thereby reducing the potential reactivity of these cells [81,88].…”
Section: Omalizumab Effects On Hyperimmunoglobulin-e Syndrome Eosinomentioning
confidence: 99%
“…Impaired mast cell apoptosis and interleukin 6 have also been postulated to be involved, as evidenced by BCL-2 up-regulation and IL-6 elevation in tissue. Some activating point mutation of c-kit in codon 816 (usually KITD816V), encoding the tyrosine kinasereceptor for stem cell factor, are found to be associated with systemic form [85][86][87][88][89][90][91][92][93][94][95][96][97][98]. Since Omalizumab reduces the expression of FcεRI on circulating basophils and mast cells, it seems to lower the activity potentials of basophils and mast cells, thereby reducing the potential reactivity of these cells [81,88].…”
Section: Omalizumab Effects On Hyperimmunoglobulin-e Syndrome Eosinomentioning
confidence: 99%
“…Mast cells are reported to form extracellular DNA-chromatin webs, with cathelicidin LL-37 attached, that may trap and kill microbes 127 . In addition to their direct antimicrobial activity they also induce cytolysis by forming membrane pores and under certain conditions suppress essential microbial intracellular functions 128 .…”
Section: Antimicrobial Peptide Receptorsmentioning
confidence: 99%
“…histamine and proteases) as well as newly synthesized mediators (e.g. prostaglandins, leukotrienes and cytokines) [31]. The physiological significance of the activated MMCs during fat absorption is unknown.…”
Section: Activation Of Mucosal Mast Cells and Release Of Mast Cell Mementioning
confidence: 99%